A Target-Specific Oral Formulation of Doxorubicin-Protein Nanoparticles: Efficacy and Safety in Hepatocellular Cancer

Background/Aims: Hepatocellular carcinoma (HCC) also known as malignant hepatoma is a most common liver cancer. Doxorubicin (Doxo) is an anti-cancer drug having activity against a wide spectrum of cancer types. Clinical Utility of doxo has been limited due to its poor bioavailability and toxicity to...

Descripción completa

Detalles Bibliográficos
Autores principales: Golla, Kishore, Bhaskar, Cherukuvada, Ahmed, Farhan, Kondapi, Anand K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2013
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3805992/
https://www.ncbi.nlm.nih.gov/pubmed/24155776
http://dx.doi.org/10.7150/jca.7093

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3805992/
https://www.ncbi.nlm.nih.gov/pubmed/24155776
http://dx.doi.org/10.7150/jca.7093

Ejemplares similares